WHO to prequalify Island Pharma’s Ebola drug by 2026-12-31
Resolves: WHO publishes official prequalification decision for Island Pharma’s Ebola treatment on its prequalification list before 2026-12-31
user-generated· regulatory
WHO to prequalify Island Pharma’s Ebola drug by 2026-12-31
Market overview
Emergency use approval often precedes WHO prequalification, a critical step for global distribution. Given the urgent public health context, WHO may expedite review and grant prequalification within 6 months of the emergency authorization.
regulatory prediction market
- Implied probability (Yes)
- 60%
- Closes
- 2026-12-31
About this prediction
Resolution criteria
WHO publishes official prequalification decision for Island Pharma’s Ebola treatment on its prequalification list before 2026-12-31
Source: user-generated
More regulatory markets
- OpenAI faces regulatory action over child safety by Q2 2027 — 60% Yes
- Ofcom introduces new mandatory cancellation rules for UK broadband providers by March 2027 — 85% Yes
- Thailand’s energy minister announces policy incentives for crude diversification — 60% Yes
- EU regulatory action reduces Google AI training data by 20% within 12 months — 62% Yes
- Trump imposes AI export restrictions on Anthropic — 40% Yes
- SEC approves stricter crypto custody rules by year-end — 60% Yes
- Democrats officially endorse ICE abolition platform — 60% Yes
- India bans highly toxic pesticides by 2027 — 75% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…